                         SEQUENCE LISTING

<110>  Roche Innovation Center Copenhagen A/S
 
<120>  IN VITRO TOXICITY SCREENING ASSAY

<130>  P33498-WO

<150>  PCT/EP2015/076967
<151>  2015-11-18

<150>  PCT/EP2015/076971
<151>  2015-11-18

<150>  EP15191075.9
<151>  2015-10-22

<150>  EP 15195198.5
<151>  2015-11-18

<150>  PCT/EP2015/079915
<151>  2015-12-16

<150>  EP 15191076.7
<151>  2015-10-22

<150>  EP 15195202.5
<151>  2015-11-18

<150>  EP 16161820.2
<151>  2016-03-23

<150>  EP16174974.2
<151>  2016-06-17

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  DNA
<213>  artificial

<220>
<223>  Oligonucleotide sequence

<400>  1
caaaggaaac acacat                                                       16


<210>  2
<211>  16
<212>  DNA
<213>  artificial

<220>
<223>  Oligonucleotide sequence

<400>  2
caaatgctga aactat                                                       16


<210>  3
<211>  16
<212>  DNA
<213>  artificial

<220>
<223>  Oligonucleotide sequence

<400>  3
ctcaacatca agcagt                                                       16


<210>  4
<211>  16
<212>  DNA
<213>  artificial

<220>
<223>  Oligonucleotide sequence

<400>  4
actgctttcc actctg                                                       16


<210>  5
<211>  16
<212>  DNA
<213>  artificial

<220>
<223>  Oligonucleotide sequence

<400>  5
gcctcccagt tccttt                                                       16


<210>  6
<211>  14
<212>  DNA
<213>  artificial

<220>
<223>  Oligonucleotide sequence

<400>  6
gatgcctccc agtt                                                         14


<210>  7
<211>  13
<212>  DNA
<213>  artificial

<220>
<223>  Oligonucleotide sequence

<400>  7
gacattgcct cta                                                          13


<210>  8
<211>  16
<212>  DNA
<213>  Artificial

<220>
<223>  Oligonucleotide sequence

<400>  8
cacattcctt gctctg                                                       16


